Moore David Scott
Director · Corvus Pharmaceuticals, Inc.
Every open-market stock purchase Moore David Scott has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where how the prices paid compare to where the stock trades now.
Where the buys stand today
- CRVS+31.6% vs price paidCorvus Pharmaceuticals, Inc.
One purchase totalling $250.2K at an average of $11.53 per share; the stock last traded at $15.17. See all insider buying in CRVS →
Avg price paid$11.53Latest price$15.17Market cap$1.3B
All reported buys
Get alerted the next time Moore David Scott — or any insider — buys
We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.
About this data
Figures are parsed from Moore David Scott's Form 4 filings on SEC EDGAR (CIK 2088466) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.